Stan van Keulen1, Naoki Nishio2, Shayan Fakurnejad2, Nynke S van den Berg2, Guolan Lu2, Andrew Birkeland2, Brock A Martin3, Tymour Forouzanfar4, A Dimitrios Colevas5, Eben L Rosenthal6. 1. Department of Otolaryngology, Division of Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA; Department of Oral and Maxillofacial Surgery/Oral Pathology, VU University Medical Center/Academic Centre for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands. 2. Department of Otolaryngology, Division of Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA. 3. Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA. 4. Department of Oral and Maxillofacial Surgery/Oral Pathology, VU University Medical Center/Academic Centre for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands. 5. Department of Medicine, Division of Medical Oncology, Stanford University School of Medicine, Stanford, CA. 6. Department of Otolaryngology, Division of Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA. Electronic address: elr@stanford.edu.
Abstract
BACKGROUND: In head and neck cancer, surgical resection using primarily visual and tactile feedback is considered the gold standard for solid tumors. Due to high numbers of tumor-involved surgical margins, which are directly correlated to poor clinical outcomes, intraoperative optical imaging trials have rapidly proliferated over the past 5 years. However, few studies report on intraoperative in situ imaging data that could support surgical resection. To demonstrate the clinical application of in situ surgical imaging, we report on the imaging data that are directly (ie in real-time) available to the surgeon. STUDY DESIGN: Fluorescence intensities and tumor-to-background ratios (TBRs) were determined from the intraoperative imaging data-the view as seen by the surgeon during tumor resection-of 20 patients, and correlated to patient and tumor characteristics including age, sex, tumor site, tumor size, histologic differentiation, and epidermal growth factor receptor (EGFR) expression. Furthermore, different lighting conditions in regard to surgical workflow were evaluated. RESULTS: Under these circumstances, intraoperative TBRs of the primary tumors averaged 2.2 ± 0.4 (range 1.5 to 2.9). Age, sex, tumor site, and tumor size did not have a significant effect on open-field intraoperative molecular imaging of the primary tumors (p > 0.05). In addition, variation in EGFR expression levels or the presence of ambient light did not seem to alter TBRs. CONCLUSIONS: We present the results of successful in situ intraoperative imaging of primary tumors alongside the optimal conditions with respect to both molecular image acquisition and surgical workflow. This study illuminates the potentials of open-field molecular imaging to assist the surgeon in achieving successful cancer removal.
BACKGROUND: In head and neck cancer, surgical resection using primarily visual and tactile feedback is considered the gold standard for solid tumors. Due to high numbers of tumor-involved surgical margins, which are directly correlated to poor clinical outcomes, intraoperative optical imaging trials have rapidly proliferated over the past 5 years. However, few studies report on intraoperative in situ imaging data that could support surgical resection. To demonstrate the clinical application of in situ surgical imaging, we report on the imaging data that are directly (ie in real-time) available to the surgeon. STUDY DESIGN: Fluorescence intensities and tumor-to-background ratios (TBRs) were determined from the intraoperative imaging data-the view as seen by the surgeon during tumor resection-of 20 patients, and correlated to patient and tumor characteristics including age, sex, tumor site, tumor size, histologic differentiation, and epidermal growth factor receptor (EGFR) expression. Furthermore, different lighting conditions in regard to surgical workflow were evaluated. RESULTS: Under these circumstances, intraoperative TBRs of the primary tumors averaged 2.2 ± 0.4 (range 1.5 to 2.9). Age, sex, tumor site, and tumor size did not have a significant effect on open-field intraoperative molecular imaging of the primary tumors (p > 0.05). In addition, variation in EGFR expression levels or the presence of ambient light did not seem to alter TBRs. CONCLUSIONS: We present the results of successful in situ intraoperative imaging of primary tumors alongside the optimal conditions with respect to both molecular image acquisition and surgical workflow. This study illuminates the potentials of open-field molecular imaging to assist the surgeon in achieving successful cancer removal.
Authors: Hannah N Rinehardt; Sadie Longo; Ryan Gilbert; Jennifer N Shoaf; Wilson B Edwards; Gary Kohanbash; Marcus M Malek Journal: Cancers (Basel) Date: 2022-04-29 Impact factor: 6.575
Authors: Hielke M de Vries; Elise Bekers; Matthias N van Oosterom; M Baris Karakullukcu; Henk G van; Fijs W B van Leeuwen; Tessa Buckle; Oscar R Brouwer Journal: J Nucl Med Date: 2021-05-14 Impact factor: 11.082
Authors: Fortuné M K Elekonawo; Jan Marie de Gooyer; Desirée L Bos; David M Goldenberg; Otto C Boerman; Lodewijk A A Brosens; Andreas J A Bremers; Johannes H W de Wilt; Mark Rijpkema Journal: Cancers (Basel) Date: 2020-04-17 Impact factor: 6.639
Authors: Naoki Nishio; Nynke S van den Berg; Brock A Martin; Stan van Keulen; Shayan Fakurnejad; Eben L Rosenthal; Katheryne E Wilson Journal: J Nucl Med Date: 2020-10-02 Impact factor: 10.057
Authors: Giri Krishnan; Nynke S van den Berg; Naoki Nishio; Georgina Juniper; Jaqueline Pei; Quan Zhou; Guolan Lu; Yu-Jin Lee; Kimberly Ramos; Andrei H Iagaru; Fred M Baik; Alexander D Colevas; Brock A Martin; Eben L Rosenthal Journal: Theranostics Date: 2021-05-24 Impact factor: 11.556